Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q3 2025 · 10-Q
Revenue—
Net Income-$3.43M-$3.43MN/M vs Q3 2024 EPS Diluted-$1.16-$1.16N/M vs Q3 2024 Operating Income-$3,475,828N/M Operating Cash Flowderived-$4,441,083N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
Free Cash Flowderived-$4,441,083N/M ended Sep 30, 2025 · filed Nov 13, 2025 · 44 d after period end